Clinicopathological profile of orbital exenteration: 14 years of experience from a tertiary eye care center in South India

详细信息    查看全文

• 作者：Mohammad Javed Ali ; Aditi Pujari ; Tarjani Vivek Dave…
• 关键词：Orbit ; Exenteration ; Ocular surface squamous neoplasia ; Sebaceous gland carcinoma ; Awareness ; Malignancy
• 刊名：International Ophthalmology
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：36
• 期：2
• 页码：253-258
• 全文大小：1,964 KB
• 参考文献：1.Bartisch G (1583) Ophthalmodoulcia. Dresden 3:208
  2.Rahman I, Cook AE, Leatherbarrow B (2005) Orbital exenteration: a 13 year Manchester experience. Br J Ophthalmol 89:1335–1340CrossRef PubMed PubMedCentral
  3.Shields JA, Shields CL, Demirci H, Honavar SG, Singh AD (2001) Experience with eyelid-sparing orbital exenteration. The 2000 Tullos O Coston Lecture. Ophthal Plast Reconstr Surg 17:355–361CrossRef PubMed
  4.Bartley GB, Garity JA, Waller RR, Henderson JW, Ilstrup DM (1989) Orbital exenteration at Mayo clinic 1967–1986. Ophthalmology 96:468–473CrossRef PubMed
  5.Pushker N, Kashyap S, Balasubramanya R et al (2004) Pattern of orbital exenteration in a tertiary eye care center in India. Clin Exp Ophthalmol 32:51–54CrossRef
  6.Mohr C, Esser J (1997) Orbital exenteration: surgical and reconstructive strategies. Graefes Arch Clin Exp Ophthalmol 235:288–295CrossRef PubMed
  7.Levin PS, Dutton JJ (1991) A 20 year series of orbital exenteration. Am J Ophthalmol 112:496–501CrossRef PubMed
  8.Rathbun JE, Beard C, Quickert MH (1971) Evaluation of 48 cases of orbital exenteration. Am J Ophthalmol 72:191–192CrossRef PubMed
  9.Naquin HA (1954) Exenteration of orbit. Arch Ophthalmol 51:850–851CrossRef
  10.Mouriaux F, Martinot V, Pellerin P, Patenotre P, Rouland JF, Constantinides G (1999) Survival after malignant tumors of the orbit and periorbita treated with exenteration. Acta Ophthalmol Scand 77:326–330CrossRef PubMed
  11.Soysal HG (2010) Orbital exenteration: a ten year experience of a general oncology hospital. Orbit 29:135–139CrossRef PubMed
  12.Nassab RS, Thomas SS, Murray D (2007) Orbital exenteration for advanced periorbital skin cancers: 20 years experience. J Plast Reconstr Aesthet Surg 60:1103–1109CrossRef PubMed
  13.Maheshwari R (2010) Review of orbital exenteration from an eye care center in western India. Orbit 29:35–38CrossRef PubMed
  14.Kaur A, Khattri M, Jaiswal V (2012) Pattern of orbital exenteration at a tertiary eye care center in North India. Nepal J Ophthalmol 4:64–67PubMed
  15.Simons JN, Robinson DW, Masters FW (1996) Malignant tumors of the orbit and periorbital structures treated with exenteration. Plast Reconstr Surg 1996(37):100–104
  16.Spaeth EB (1971) Information learned from 50 years of orbital exenteration. Trans Ophthalmol Soc UK 91:611–634PubMed
  17.Kennedy RE (1979) Indications and surgical techniques for orbital exenteration. Ophthalmology 86:967–973CrossRef PubMed
  18.Putterman AM (1986) Orbital exenteration with spontaneous granulation. Arch Ophthalmol 104:139–140CrossRef PubMed
  19.Shields JA, Shields CL, Suvarnamani C, Tantisira M, Shah P (1991) Orbital exenteration with eyelid sparing: indications, techniques and results. Ophthal Surg 22:292–297
  20.Wong JC, Thampy R, Cook A (2014) Life expectancy following orbital exenteration. Br J Ophthalmol (Epub)
  21.Lee PS, Sedrak P, Guha-Thakurta N et al (2014) Imaging findings of recurrent tumors after orbital exenteration and free flap reconstruction. Ophthal Plast Reconstr Surg 30:315–321CrossRef PubMed
  
• 作者单位：Mohammad Javed Ali (1)
  Aditi Pujari (1)
  Tarjani Vivek Dave (1)
  Swathi Kaliki (1)
  Milind N. Naik (1)
  
  1. Ophthalmic Plastics Surgery Service, L.V.Prasad Eye Institute, Road No 2, Banjara Hills, Hyderabad, 34, India
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Ophthalmology
  
• 出版者：Springer Netherlands
• ISSN：1573-2630

文摘

This study aims to describe the clinicopathological features and outcomes of patients who underwent orbital exenteration at a tertiary eye care center in south India. Retrospective chart reviews were performed on all patients undergoing orbital exenteration from January 1999 to December 2012. Parameters recorded include demographic data, clinical presentations, past medical or surgical interventions, exenteration notes, histopathological diagnosis, adjunctive treatment, follow-up examination findings, recurrences, complications, and their management. Orbital exenteration was performed on 119 orbits of 119 patients over a 14-year period. The mean age was 48.9 years (range 1–82 years). The indications were malignancies in 90.7 % (108/119), while 9.3 % (11/119) of cases were exenterated for non-malignant indications. Among the malignancies, the commonest tissue of origin was conjunctiva, noted in 45.4 % (49/108), followed by eyelids (25.9 %, 28/108), orbit (19.4 %, 21/108), and intraocular tissues (9.3 %, 10/108). The commonest malignancies noted in this series were an extensive ocular surface squamous neoplasia (OSSN) (44.4 %, 48/108) and sebaceous gland carcinoma of eyelids with an orbital involvement (18.5 %, 20/108). Extensive fungal granuloma (mucormycosis-4, aspergillosis-4) was the commonest (81.8 %, 9/11) indication among the non-malignant group. All complications were wound related, and none had a recurrence at a mean follow-up of 12.8 months. Extensive orbital involvement with OSSN and SGC were the commonest indications for exenteration. There is a need of creating awareness among general ophthalmologists in specific geographical regions regarding early diagnosis, standardized protocols of management, and appropriate referral.